Affirm Health Ltd.

PUBLIC

Name	Affirm Health Ltd. (trading as Proceive)
Tagline	Provider of the Proceive line of fertility, pregnancy, and post-pregnancy nutritional supplements.
Headquarters	Dublin, Ireland
Founded	2017
Business Model	Direct-to-Consumer (DTC)
Industry	Healthtech
Technology	No Technology Component
Geography	Western Europe
Founding Team	Solo Founder

Links

PUBLIC

• Website: https://proceive.com/
• LinkedIn: https://ie.linkedin.com/company/affirm-health

Executive Summary

PUBLIC Affirm Health Ltd. is a Dublin-based consumer health company operating the Proceive brand, a line of high-strength nutritional supplements for fertility, pregnancy, and post-pregnancy support. The company merits attention as a bootstrapped, founder-led business that has carved out a defensible niche in a crowded wellness category by focusing on research-backed, stage-specific formulations for both men and women [Perplexity Sonar Pro Brief, retrieved 2024].

Founder Graham Stafford launched the range in 2017 after identifying a gap between emerging fertility science and the broad-spectrum multivitamins then available [Perplexity Sonar Pro Brief, retrieved 2024]. The core product differentiation rests on clinical data and high-potency nutrient doses, such as the 1,038mg per daily serving in Proceive Women, which the company positions as one of the highest on the market [Proceive, retrieved 2024].

Stafford is also the CEO and Founder of Ocean Healthcare, indicating broader experience in the healthcare sector, though his specific background prior to Proceive is not detailed in public materials [LinkedIn, retrieved 2026]. The company appears to be entirely self-funded or privately capitalized, with no disclosed funding rounds or institutional investors, and operates on a direct-to-consumer model supplemented by retail partnerships with major UK and Irish pharmacy chains like Boots and Holland & Barrett [Perplexity Sonar Pro Brief, retrieved 2024].

Over the next 12-18 months, the key monitorables are the company's ability to scale its retail footprint beyond its current channels, any potential moves into adjacent health categories or digital services, and whether it seeks external capital to accelerate growth. The primary external risk remains potential brand confusion due to a namesake individual's unrelated legal history, a factor requiring clear disambiguation [Spotify, retrieved 2026].

Data Accuracy: YELLOW -- Core product and company details are confirmed by the company's own website and a limited external profile; funding, detailed team background, and financial metrics are not publicly available.

Taxonomy Snapshot

Axis	Classification
Business Model	Direct-to-Consumer (DTC)
Industry / Vertical	Healthtech
Technology Type	No Technology Component
Geography	Western Europe
Founding Team	Solo Founder

Company Overview

PUBLIC

Affirm Health Ltd. is the legal entity operating the Proceive brand, a line of fertility and pregnancy nutritional supplements based in Dublin, Ireland. The company was founded in 2017 by Graham Stafford, who identified a gap between scientific research on fertility and the available supplement products on the market [proceive.com, retrieved 2024]. The founding narrative positions Proceive as a response to this gap, launching with high-strength, research-backed nutrient formulations rather than broad-spectrum multivitamins [Perplexity Sonar Pro Brief, retrieved 2024].

Key operational milestones are limited to brand development and market positioning. The product line launched in 2017. The company participates in the Guaranteed Irish program, a marketing initiative for Irish-made products, which has featured Proceive in promotional content [Guaranteed Irish Official Facebook, 2023-2024 timeframe]. Retail distribution has expanded to include selected Boots and Holland & Barrett stores in addition to direct online sales [proceive.com, retrieved 2024]. The company currently employs 12 individuals [LinkedIn, retrieved 2024].

Data Accuracy: YELLOW -- Company details confirmed via its own website and LinkedIn; founding story and milestones are single-source from company materials.

Product and Technology

MIXED

Proceive's product line is a collection of nutritional supplements, a category defined by formulation science rather than software or hardware. The brand's core proposition is a series of high-strength, research-backed nutrient blends tailored to specific stages of the reproductive journey, from pre-conception through post-pregnancy [proceive.com, retrieved 2024]. This stage-specific approach is the primary differentiator the company communicates, moving away from generic multivitamins toward targeted formulations for men and women.

• Product Range. The line includes Proceive Men and Proceive Women for fertility support, alongside pregnancy and post-pregnancy variants. The company claims its Women's formula delivers 1,038mg of nutrition per daily dose, which it positions as one of the highest on the market [Proceive, retrieved 2024].
• Quality and Sourcing. Public customer reviews frequently cite the product's quality, gentle nature, and inclusion of specific nutrients like l-methylfolate and CoQ10 as positive attributes [Trustpilot, retrieved 2026]. The company's participation in the Guaranteed Irish program also serves as a public signal of its Irish manufacturing and sourcing standards [Guaranteed Irish Official Facebook].
• Distribution. The commercial model is direct-to-consumer, with products sold through the company's own e-commerce site and through selected retail partners, including Boots and Holland & Barrett stores [proceive.com, retrieved 2024].

There is no publicly described technology stack, digital product, or software layer associated with the Proceive brand. The business operates as a consumer packaged goods company within the nutraceutical space, with its 'technology' residing in its proprietary formulations and clinical research positioning.

Data Accuracy: GREEN -- Product details and claims are confirmed by the company's own website and retail partner listings. Customer sentiment is corroborated by third-party review platforms.

Market Research

PUBLIC

Understanding the market for Proceive requires examining the intersection of consumer health, fertility awareness, and the nutritional supplement industry, a space where demographic and behavioral shifts are creating sustained demand.

The total addressable market for fertility and pregnancy supplements is not quantified in public disclosures from Affirm Health. Industry reports on the broader global dietary supplements market provide a useful, if indirect, analog. The global market for vitamins and dietary supplements was valued at approximately $170 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of around 7% through 2030 [Grand View Research, 2024]. The prenatal vitamins segment, a key adjacent category, is a significant driver of this growth. More specific to Proceive's positioning, the global fertility supplements market was estimated at $2.7 billion in 2022 and is forecast to reach $4.9 billion by 2032, growing at a CAGR of 6.1% [Allied Market Research, 2023]. These figures suggest a substantial and expanding market for targeted nutritional support.

Several demand drivers underpin this growth. A primary factor is the trend of delayed parenthood in developed economies, which correlates with increased consumer interest in proactive fertility support for both men and women. Growing public awareness of the role of specific micronutrients, such as folate, CoQ10, and zinc, in reproductive health has shifted demand from generic multivitamins to specialized, high-potency formulations. The direct-to-consumer (DTC) model, which Proceive employs, has also lowered barriers to purchase for sensitive health categories, allowing brands to reach consumers directly with targeted messaging. Finally, a broader cultural movement towards personalized wellness and preventative health continues to fuel spending in the supplement sector.

Proceive's market is flanked by several adjacent and substitute categories. The most direct substitute is the broader prenatal and multivitamin aisle at major retailers, where generalist brands compete on price and brand recognition. Adjacent markets include the fertility testing and tracking sector, comprising at-home hormone test kits and ovulation monitors, which often serve as a complementary purchase. The broader wellness and 'femtech' space, which includes apps and services for menstrual health and pregnancy, represents another adjacent ecosystem where partnerships or bundling could occur. The company's focus on a science-backed, high-strength formulation positions it against clinical-grade nutraceuticals rather than mass-market supplements.

Regulatory and macro forces present a mixed picture. The supplement industry is generally less stringently regulated than pharmaceuticals, allowing for faster product development and launch. However, this also creates a landscape crowded with claims that can be difficult for consumers to verify, placing a premium on trusted branding and transparent sourcing. Economic pressures can influence discretionary spending on premium supplements, though health-related purchases often prove resilient. For an Irish brand like Proceive, participation in the Guaranteed Irish program is a positive macro factor, leveraging consumer preference for locally produced goods and potentially insulating the brand from supply chain volatility affecting international competitors.

Global Fertility Supplements Market (2022) | 2.7 | $B
Projected Market (2032) | 4.9 | $B

The projected near-doubling of the fertility supplements market over a decade indicates a structural tailwind, but growth is measured rather than explosive. Proceive's success will depend on capturing share within this growing niche against established competitors, rather than riding a hyper-growth wave.

Data Accuracy: YELLOW -- Market sizing figures are drawn from third-party industry reports, not company disclosures. The application of these broader market figures to Proceive's specific SAM and SOM is not publicly quantified.

Competitive Landscape

MIXED

Proceive operates in a crowded, well-established consumer supplements category, where its primary competition comes from established mass-market brands and specialist fertility-focused labels, rather than from venture-backed healthtech startups.

Company	Positioning	Stage / Funding	Notable Differentiator	Source
Affirm Health (Proceive)	High-strength, research-backed fertility and pregnancy supplements for men and women.	Private company; no public funding.	Formulations positioned as higher-dose and more targeted than broad multivitamins; early focus on both male and female preconception.	[proceive.com, retrieved 2024]
Pregnacare Max	Comprehensive pregnancy and preconception vitamin range from a major consumer health brand.	Brand owned by Vitabiotics Ltd., a large private UK nutraceutical company.	Mass-market retail distribution and strong brand recognition in the UK and Ireland.	[Public]
Wild Nutrition Fertility Support	Food-grown, practitioner-recommended supplements for hormone balance and fertility.	Private company; direct-to-consumer and practitioner channels.	Emphasizes food-state, whole-food complex ingredients and practitioner endorsements.	[Public]
Zita West	Holistic fertility clinic and supplement brand founded by a leading fertility expert.	Integrates clinic services, products, and books; premium positioning.	Direct link to a high-profile clinical practice and expert authority.	[Public]
Impryl	Medical food supplement for male and female fertility, focused on oxidative stress.	Available in pharmacies and clinics; positioned as a medical product.	Specific scientific mechanism targeting antioxidant pathways; often recommended in clinical settings.	[Public]
Proxeed	Sperm-quality-focused supplement for men, backed by clinical studies.	Marketed as a medical device in some regions; strong clinical marketing.	Targeted, single-gender focus with published clinical data on sperm parameters.	[Public]

The competitive map segments into three tiers. The mass-market incumbents, like Pregnacare, compete on ubiquity and trust, holding dominant shelf space in major retailers like Boots where Proceive also seeks placement. Specialist challengers, including Wild Nutrition and Zita West, compete on ingredient purity, holistic philosophy, or direct expert affiliation. Finally, medicalized substitutes like Impryl and Proxeed compete on clinical evidence and prescription-adjacent positioning, often targeting consumers through fertility clinics rather than general retail.

Proceive’s current defensible edge appears to be its specific formulation claim and dual-gender focus from launch. The company cites a daily dose of 1,038mg for its women's product as "one of the highest on the market" and positions its entire line as "research-backed" rather than generic multivitamins [Proceive, retrieved 2024]. This technical, dosage-focused messaging is a point of differentiation against broad-spectrum brands. However, this edge is perishable; formulation is easily replicable, and the "high-strength" claim is a marketing feature, not a patent-protected technology. Durability hinges on brand loyalty and retail relationships, not on an insurmountable technical moat.

The company’s most significant exposure is in distribution and brand authority. While Proceive is sold in selected Boots and Holland & Barrett stores, it lacks the ubiquitous retail presence of a Pregnacare or the clinical endorsement network of a Zita West or Impryl. Its online direct-to-consumer channel faces intense competition from digitally-native supplement brands with larger marketing budgets. Furthermore, the founder-led, lean structure with 12 employees [2][4] may limit sales and marketing reach compared to larger, better-capitalized rivals.

The most plausible 18-month scenario is further fragmentation within the specialist fertility supplement niche. A "winner" in this segment would likely be a brand that successfully partners with a major retail pharmacy chain for an exclusive line or secures a formal recommendation from a national health service, driving volume and trust. A "loser" would be a brand that fails to move beyond a direct-to-consumer website and limited retail trial, remaining a niche player. For Proceive, the path to winning involves deepening its existing retail partnerships and potentially expanding its "Guaranteed Irish" marketing angle [Guaranteed Irish Official Facebook] into a stronger national identity, while the risk of losing share grows if a mass-market incumbent launches a directly comparable, high-dose sub-brand.

Data Accuracy: YELLOW -- Competitor profiles and Proceive's positioning are confirmed by public brand materials and retail presence. Funding and detailed market share data for competitors are not publicly disclosed.

Opportunity

PUBLIC

For a direct-to-consumer supplements brand in a fragmented but emotionally charged category, the core opportunity is to establish a dominant, trusted identity in a specific health journey, moving from a product line to a platform for lifelong customer relationships.

The headline opportunity is to become the definitive, science-backed nutritional brand for the entire reproductive health lifecycle in the UK and Ireland, and eventually across Europe. The cited evidence suggests this is reachable rather than purely aspirational because the company has already established a clear, high-strength product wedge with positive consumer reception. Proceive has carved out a position based on "high-strength, research-backed nutrient formulations" rather than general multivitamins, a distinction it has communicated since launch [Perplexity Sonar Pro Brief, retrieved 2024]. Its products are already stocked in major retail pharmacies Boots and Holland & Barrett, providing critical shelf-space validation [proceive.com, retrieved 2024]. With a 4.4-star average rating for a key product on a major retailer's site, the brand demonstrates an ability to meet consumer expectations in a sensitive category [proceive.com, retrieved 2024]. The path from a successful niche supplement to a trusted, household name in fertility and pregnancy care is a documented trajectory in consumer health.

Growth would likely follow one of several concrete, named paths. The following scenarios outline plausible routes to significant scale.

Scenario	What happens	Catalyst	Why it's plausible
Retail Dominance	Proceive becomes the leading fertility/pregnancy supplement brand in UK & Irish pharmacy chains, expanding shelf space and launching exclusive product lines.	A formal national listing agreement with a major retailer like Boots, supported by strong in-store sales data.	The brand is already sold in "selected Boots and Holland & Barrett stores," proving channel access and a baseline of buyer demand [proceive.com, retrieved 2024]. Category leaders like Pregnacare have followed a similar path.
Clinic & Practitioner Channel	The brand transitions from DTC/retail into a recommended product by fertility clinics, OB/GYNs, and nutritionists, commanding premium pricing and loyalty.	A partnership with a prominent fertility clinic network or a published clinical study on Proceive's formulations.	The company's messaging is built on "the latest clinical data and scientific research," positioning it for professional endorsement [Perplexity Sonar Pro Brief, retrieved 2024]. The fertility space increasingly integrates nutrition into treatment plans.
Geographic Expansion	Proceive replicates its Irish/UK model in other European markets with similar healthcare and retail structures, such as Germany or the Nordics.	Securing a distributor partnership or achieving regulatory approval (e.g., EFSA health claims) for key markets.	The company's participation in the "Guaranteed Irish" program shows an initial focus on national identity, a common first step before international rollout [Guaranteed Irish Official Facebook, 2023-2024]. The underlying consumer need is not geographically limited.

What compounding looks like for Proceive is a classic brand-and-data flywheel in a high-trust category. Initial retail placements generate revenue and broader consumer awareness. Positive customer experiences, reflected in reviews and repeat purchases, strengthen brand equity and provide testimonials for securing more retail space and professional recommendations. This growth in user base could, over time, generate valuable, aggregated data on supplement usage and consumer health goals,insights that could inform future product development (e.g., formulations for menopause) or even service offerings. Each step reinforces the next: retail wins build brand trust, which opens the clinic channel, which further validates the brand for retail expansion. The early signals of this loop are present in the form of customer praise for quality and the nutritional profile, which the company highlights on its site [proceive.com, retrieved 2024].

The size of the win can be framed by looking at a comparable category leader. Vitabiotics, the maker of Pregnacare, is a privately held UK company with an estimated annual turnover in the hundreds of millions of pounds, demonstrating the scale possible for a trusted brand in the pregnancy supplement space. While direct financials for Vitabiotics are not public, its market presence and longevity serve as a proxy. If the Retail Dominance scenario plays out, Proceive could aim to capture a material portion of this established market. A successful exit in this space might not be a venture-scale unicorn valuation but could resemble a strategic acquisition by a large consumer health or pharmaceutical company seeking a modern, digitally-native brand in the reproductive health segment. This represents a credible, high-value outcome for the business and its stakeholders (scenario, not a forecast).

Data Accuracy: YELLOW -- Growth scenarios are extrapolated from the company's current retail placement and brand positioning; specific expansion catalysts and comparable scale are not publicly confirmed.

Sources

PUBLIC

1. [proceive.com, retrieved 2024] Our Reviews - Proceive | https://proceive.com/pages/reviews

2. [LinkedIn, retrieved 2024] Affirm Health (Proceive) | LinkedIn | https://ie.linkedin.com/company/affirm-health

3. [Perplexity Sonar Pro Brief, retrieved 2024] Affirm Health Ltd. / Proceive Company Brief | [URL from raw research]

4. [Proceive, retrieved 2024] Proceive | Fertility & Pregnancy Nutrition - 25% Off + Free Delivery* | https://proceive.com/

5. [Guaranteed Irish Official Facebook, 2023-2024 timeframe] Guaranteed Irish - Facebook video | https://www.facebook.com/GuaranteedIrish/videos/4-reasons-why-affirm-health-proceive-produces-the-best-fertility-and-pregnancy-s/1089904995400262/

6. [LinkedIn, retrieved 2026] Affirm Health | LinkedIn | https://www.linkedin.com/company/affirmhealth

7. [Trustpilot, retrieved 2026] Proceive Reviews | Read Customer Service Reviews of proceive.com | https://uk.trustpilot.com/review/proceive.com

8. [Spotify, retrieved 2026] 'Graham Stafford - A Killer, Accomplice, or Victim? You Decide' - Who Killed Leanne Holland? | Podcast on Spotify | https://open.spotify.com/episode/0elmynOcCDmqkwsPYIlWMq

9. [Grand View Research, 2024] Vitamins & Dietary Supplements Market Size Report, 2024-2030 | [URL from raw research]

10. [Allied Market Research, 2023] Fertility Supplements Market Size, Share, Competitive Landscape and Trend Analysis Report, 2023-2032 | [URL from raw research]